http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ee920573689aeec1de730f9c735ea9f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Martin |
| name | Miguel Martin |
| given-name | Miguel |
| organization-name | 8Hospital Universitario San Carlos, Madrid, Spain. From the Norris Comprehensive Cancer Center, University of Southern California; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles; City of Hope National Medical Center, Duarte; Cepheid, Sunnyvale, CA; University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg; Frauenklinik vom Roten Kreuz, Munich, Germany; International Drug Development Institute, Louvain-la-Neuve, Belgium; Maria Sklodowska-Curie Centre, Warsaw, Poland; Hospital Universitario San... Instituto de Investigación Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain From the University of Alberta; Cross Cancer Institute, Edmonton, Alberta; Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada; Lineberger Comprehensive Cancer Center and Departments of Genetics and Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; L'Institut National de la Santé et de la Recherche Médicale, U590; Hospices... Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain. mmartin@geicam.org Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Departamento de Medicina, Universidad Complutense, Madrid, Spain; Centro de Investigación Biomedica en Red de Oncologia, CIBERONC-ISCIII, Spain From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology–Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) — both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) — all in California; the Department... Michael F. Press, Denice D. Tsao-Wei, Yanling Ma, Ivonne Villalobos, and Anaamika Campeau, University of Southern California Norris Comprehensive Cancer Center; Dennis J. Slamon, Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA; Nicholas Robert, Virginia Cancer Specialists/US Oncology Research Network, Fairfax, VA; Vicente Valero, The University of Texas MD Anderson Cancer Center, Houston, TX; Guido Sauter and Martina Mirlacher, University of Hamburg, Hamburg;... GENYO; Pfizer-University of Granada-Junta de Andalucia Centre for Genomics and Oncological Research; 18016 Granada; Spain 2Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain. Authors' Affiliations: 1University of California at Los Angeles, Los Angeles; 2Genentech, South San Francisco, California; 3International Drug Development Institute, Louvain-la-Neuve, Belgium; 4Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; 5Virginia Cancer Specialists, US Oncology, Fairfax, Virginia; 6University of Texas MD Anderson Cancer Center, Houston, Texas; 7St. Vincent's Hospital, Dublin, Ireland; 8University of Alabama at Birmingham, Birmingham, Alabama; 9University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 10Cancer Center, Warsaw, Poland; 11Redcross Women's Hospital, Muenchen, Germany; 12Hospital Gregorio Maranon, Madrid, Spain; and 13Breast Cancer International Research Group (BCIRG), Paris, France Universidad Complutense, CUBERONC, GEICAM, Madrid, Spain From The University of Texas M.D. Anderson Cancer Center, Houston, TX; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona; Servicio Oncologia, Hospital Clinico Universitario, Valencia; Hospital Clinico San Carlos, Prof Martin Lagos S/N, Madrid, Spain; Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Oncology and Hematology, University Hospital, Modena, Italy; Centre Georges-François Leclerc, Dijon, France; Weill Cornell Medical College/New York Presbyterian... Hospital Universitario San Carlos, Servicio de Oncologia Médica, Madrid, Spain From the Hospital of Prato, Prato, Italy; Centre Hospitalier Universitaire Sart Tilman, Liège; AZ. Klina, Brasschaat, Belgium; Charles University, Prague, Czech Republic; Instituto Nacional del Cáncer, Santiago, Chile; Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine; Republican Clinical Oncological Center, Kazan; Medical Radiological Science Center, Obninsk; Russian Cancer Research Centre, Moscow, Russia; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; Kansas City Cancer... Hospital Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Instituto de Investigacion Sanitaria Gregorio Marañon, Ciberonc, Geicam, Universidad Complutense, Madrid, Spain Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain Authors' Affiliations: 1Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre; 2Servicio de Oncología Médica, Hospital Universitario Gregorio Marañón; 3Servicio de Oncología Médica, Hospital Universitario San Carlos; and 4Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain Authors' Affiliations: 1Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain; 2Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia; 3Clinique Victor Hugo–Centre Jean Bernard, Cedex 2, France; 4University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 5Onkologische Schwerpunktpraxis, Mannheim, Germany; 6Institutul Oncologic Ion Chiricuta, Cluj-Napoca, Romania; 7Cancer Research UK, University of Sussex, Falmer, Brighton, United Kingdom; 8National Cancer Center Hospital, Tokyo, Japan; 9Medical University of Gdansk, Gdańsk, Poland; 10Tom Baker Cancer Centre, Calgary, Alberta, Canada; 11Beatson Oncology Centre, Glasgow, Scotland, United Kingdom; 12Allgemeines Krankenhaus St. Georg, Clinical Division of Oncology, Waehringer Guertel, Vienna, Austria; 13Arizona Cancer Center, University of Arizona, Tucson, Arizona; 14Sylvester Comprehensive Cancer Center at Deerfield, Deerfield Beach, Florida; and Departments of 15Biostati Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid , Madrid , Spain Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), Stem Cells Department, Sevilla, Spain.; Hospital Virgen de la Victoria, Fundación IMABIS, Malaga, Spain. Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón Universidad Complutense, Madrid, Spain Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain Department of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, GEICAM, Madrid, Spain. Servicio de Oncología Médica, Instituto de Investigacion Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain. Cristina Saura and Javier Cortés, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona; Jose A. Garcia-Saenz, Hospital Clinico San Carlos; Miguel Martin, Hospital Gregorio Maranon, Universidad Complutense, Madrid, Spain; Binghe Xu, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Wael Harb, Horizon Medical Group, Lafayette, IN; Rebecca Moroose, University of Florida Health Cancer Center, Orlando, FL; Timothy Pluard, Washington University School of... Hospital General Universitario Gregorio Marañon, Universidad Complutense, Madrid, Spain; Authors' Affiliations: 1Institut National de la Santé et de la Recherche Médicale 590, Lyon, France; 2Burnham Institute for Medical Research, La Jolla, California; 3Cross Cancer Institute, Edmonton, Canada; 4Hospital Universitario San Carlos, Madrid, Spain; 5Cancer International Research Group, Paris, France; and 6Commissariat à l'Energie Atomique, Grenoble, France Red Cross Clinics, Women's Hospital, München, Germany; Breast Cancer Clinic, Warsaw, Poland; All-Ireland Co-Operative Oncology Research Group, Dublin, Ireland; Hospital Universitario San Carlos, Madrid; Spain; Mount Medical Center, Perth, Australia; University of Alabama, Birmingham, AL; William Osler Health Center, Brampton Civic Hospital, Ontario; and Hôpital Saint Sacrement, Département d'Oncologie, Ville de Québec, Canada; Research Institute of Oncology n.a. N.N. Petrov Rosmedtechnologiy, St... From the Duke University Medical Center, Durham, NC (M.G.K., P.S.D., L.W.J.); Cross Cancer Institute, Edmonton, AB, Canada (J.R.M.); Hospital General Universitario Gregorio Maranon, Universidad Complutense, Madrid, Spain (M.M.); NASA Johnson Space Center, Houston, TX (J.M.S.); and Massachusetts General Hospital, Harvard Medical School, Boston (M.S.-C.). Edith A. Perez, Mayo Clinic, Jacksonville, FL; Howard A. Burris, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Jennifer A. Petersen, Genentech, South San Francisco, CA; Carlos Barrios, Pontifícia Universidade Católica do Rio Grande do Sul School of Medicine, Porto Alegre, Brazil; Wolfgang Eiermann, Interdisciplinary Oncology Center, Munich, Germany; Masakazu Toi, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Young-Hyuck Im, Samsung Medical Centre, Seoul, Korea;... Gregorio Marañón Hospital, Universidad Complutense, Madrid, Spain From the Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain. Red GRAAL, Ecuador; Universitat Autònoma de Barcelona, España; Universidad Yachay, Ecuador Hospital Universitario San Carlos, Madrid, Spain. mmartin@geicam.org Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain. Universitat Autónoma de Barcelona, Grups de Recerca d'Amèrica i Àfrica Llatines (GRAAL), Barcelona, Spain Fundacion Instituto Mediterráneo para el Avance de la Biotecnología y la Investigación Sanitaria (IMABIS) Malaga Spain; Department of Stem CellsAndalusian Centre of Molecular Biology and Regenerative Medicine(CABIMER) Seville Spain Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research... c Oncology Service, Hospital Clinico San Carlos, Madrid, Spain; Hospital General Universitario Gregorio Marañon, Complutense University, CIBERONC, GEICAM Madrid Spain The Service of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid - Spain 10Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. From the Department of Breast Medical Oncology and the Division of Quantitative Sciences, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Breast Cancer Unit, Department of Medical Oncology and Translational Research Unit, UPRES EA03535, Université Paris Sud, Institut Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Claudius Regault, Toulouse; Department of Pathology, Center Claude Perrin, Clermont-Ferrand, France; Department of Oncology, Hospital Universitario San... Servicio de Oncologia Medica, Hospital, Universitario San Carlos, 28040 Madrid, Spain, g Hospital Universitario Gregorio Marañon, Madrid, Spain; Instituto de Investigación Sanitaria Hospital Universitario Gregorio Marañón, Universidad Complutense; Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain Medical Oncology Service, Hospital General Universitario Gregorio Marañon, Universidad Complutense, Centro de Investigación Biomédica en Red-Cáncer, Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain Instituto de Investigación Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense , Madrid, Spain Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM), Universidad Complutense, Madrid, Spain John R. Mackey, Cross Cancer Institute; Francois Thireau and Helena Fung, Translational Research in Oncology, Edmonton; Marc Webster, Tom Baker Cancer Centre, Calgary, Alberta; Karen A. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia; Sunil Verma, Sunnybrook Health Sciences Center; Lorinda Simms, Eli Lilly, Toronto, Ontario, Canada; Manuel Ramos-Vazquez, Centro Oncológico de Galicia “José Antonio Quiroga y Piñeiro,” A Coruña; Miguel Martin, Instituto de Investigación Sanitaria... From The University of Texas M. D. Anderson Cancer Center, Houston, TX; Australia New Zealand Breast Cancer Trials Group, University of Newcastle, Calvary Mater Hospital, Newcastle, NSW, Australia; University of California, Los Angeles; University of Southern California, Los Angeles, CA; Marie Sklodowska-Curie Memorial Cancer Center, Warsaw and Krakow; Niepubliczny Zaklad Opieki Zdrowotnej Onko-Med, Olsztyn, Poland; Red Cross Women's Hospital, Munich; University Women's Hospital, Frankfurt, Germany;... 2Hospital Universitario San Carlos, Madrid, Spain; Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Bioinformatics and Computational Biology, and 3Pathology, The University of Texas M.D. Anderson Cancer Center; 4Lyndon B Johnson General Hospital, and The University of Texas Health Science Center, Houston, Texas; 5Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; 6Grupo Español de Investigacion en Cancer de Mama, Madrid, Spain; and 7Centro Medico Nacional de Occidente, Guadalajara, Mexico Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. Dan Rosmarin, Claire Palles, David Church, Enric Domingo, Angela Jones, Ian Tomlinson, Wellcome Trust Centre for Human Genetics, NIHR Comprehensive Biomedical Research Centre, University of Oxford; Dan Rosmarin, David Church, Elaine Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder, George Nicholson, Rachel Midgley, David Kerr, and George Nicholson, University of Oxford, Oxford; Michael Braun, The Christie NHS Foundation Trust, Manchester; Matthew Seymour, St James's University Hospital... Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM,Madrid, Spain |
Incoming Links
Total number of triples: 247.